- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/20 - Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Patent holdings for IPC class C07D 217/20
Total number of patents in this class: 83
10-year publication summary
|
3
|
0
|
2
|
2
|
3
|
4
|
7
|
4
|
5
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mallinckrodt LLC | 132 |
11 |
| SpecGx LLC | 186 |
8 |
| Dermavant Sciences GmbH | 81 |
5 |
| Chemagis Ltd. | 28 |
4 |
| Bausch + Lomb Ireland Limited | 720 |
4 |
| Takeda Pharmaceutical Company Limited | 2709 |
2 |
| Academia Sinica | 953 |
2 |
| City of Hope | 1009 |
2 |
| Cornell University | 3369 |
2 |
| Eli Lilly and Company | 3951 |
2 |
| Enanta Pharmaceuticals, Inc. | 433 |
2 |
| Mallinckrodt Inc. | 156 |
2 |
| Recordati Industria Chimica e Farmaceutica S.p.A. | 53 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 849 |
2 |
| Taipei Medical University | 209 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 867 |
2 |
| Idorsia Pharmaceuticals Ltd. | 344 |
2 |
| Novartis Pharmaceuticals Corporation | 53 |
1 |
| The Regents of the University of California | 20315 |
1 |
| University of Florida Research Foundation, Inc. | 4089 |
1 |
| Other owners | 24 |